Dr. Joseph Patrick McGraw, MD

Dr. McGraw practices at Trilogy Eye Medical Group Inc in National City, California.

Dr. McGraw's NPI, 1588624852, was assigned on March 23, 2006. Dr. McGraw graduated from Lewis Katz School of Medicine in 1991. Dr. McGraw holds California license A155228.

Dr. McGraw's primary practice is Trilogy Eye Medical Group Inc, at 655 S Euclid Ave, National City, CA 91950 in San Diego County. The practice phone is (619) 472-1010.

Dr. McGraw's primary practice is Trilogy Eye Medical Group Inc in National City, California. Dmand AI also links Dr. McGraw to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McGraw practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. McGraw's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. McGraw is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. McGraw's licenses on file in 3 states: California, Pennsylvania and Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. McGraw treats.

CMS data shows 752 Medicare services from Dr. McGraw across 14 procedure codes in 2024, for 244 Medicare patients. Medicare paid $62,553 for them.

CMS counts 244 Medicare patients who saw Dr. McGraw in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McGraw's median patient age at 73, with 59% women.

In 2024, Dr. McGraw wrote 2,556 Medicare Part D claims for 554 patients. 61% of them were for generic drugs. CMS names the drug for 2,468 of them, across 16 drugs with 11 or more claims each, at $104,623 in total drug cost. In 2023, CMS named 2,095 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. McGraw for performance year 2024, reported individually. Dr. McGraw accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 61 procedures of cataract surgery by Dr. McGraw, more than 67% of the clinicians it reports for that procedure.

CMS Open Payments shows 115 general payments to Dr. McGraw from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Bausch & Lomb Americas Inc. paid the most, $728.

Dr. McGraw graduated from Lewis Katz School of Medicine in 1991.

Dr. McGraw is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.